Opportunity Information: Apply for RFA FD 16 046
Apply for RFA FD 16 046
- The HHS-FDA in the agriculture, consumer protection sector is offering a public funding opportunity titled "Antimicrobial Use & Resistance Data Collection (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
- This funding opportunity was created on Mar 16, 2016 and posted on Mar 16, 2016.
- Applicants must submit their applications by May 24, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Antimicrobial Use and Resistance Data Collection (U01) opportunity (RFA FD 16 046) is a U.S. Food and Drug Administration (FDA) cooperative agreement designed to fund practical, on-the-ground data collection about how antimicrobials are used in animal agriculture. Released and posted on March 16, 2016, with an application deadline of May 24, 2016, the program makes FY 2016 funds available to support efforts focused specifically on food-producing animals, with production settings explicitly including cattle, swine, and poultry. The central purpose is to generate credible, detailed information on real-world antimicrobial use practices, while also testing and improving the methods used to collect and report that information so the U.S. can build better long-term monitoring systems.
A major theme of the opportunity is that it is not only about gathering numbers, but about learning how to gather the right numbers consistently. FDA is looking for projects that can capture antimicrobial use practices across different production contexts and, at the same time, provide insights into data collection methodologies that work at scale. In practice, that means funded projects are expected to contribute both substantive findings (what is being used, where, and why) and operational lessons (which data sources are feasible, what reporting formats are reliable, what barriers exist, and how to standardize approaches). Because the funding instrument is a cooperative agreement, the intent is typically closer collaboration with the agency than a standard grant, aligning project activities with federal monitoring and stewardship objectives.
The work is positioned as directly supporting the National Action Plan for Combating Antibiotic-Resistant Bacteria, particularly the objective of enhancing monitoring of antibiotic usage and management practices in food-producing animals. The data produced under this program is meant to strengthen national understanding of how antibiotics are actually used in agriculture and how those practices may relate to antimicrobial resistance trends. A key policy linkage is FDA Guidance for Industry #213, and the collected data is intended to help assess how quickly and thoroughly industry changes outlined in that guidance are being adopted. Beyond measuring adoption, the data is also meant to help evaluate the effectiveness of antibiotic stewardship efforts over time, informing how stewardship programs can be refined, expanded, and optimized based on evidence rather than assumptions.
Another stated purpose is to support analysis of potential associations between antimicrobial use practices and resistance. While the opportunity centers on use data collection, the framing makes clear that FDA wants the results to be useful for connecting use patterns to resistance concerns, helping regulators, researchers, and industry stakeholders understand which practices may be higher risk, which interventions appear promising, and where additional monitoring is most needed. In that sense, the program sits at the intersection of agriculture, consumer protection, and public health, aiming to improve transparency and decision-making around antimicrobial stewardship in the food system.
Funding details indicate an award ceiling of $300,000 and an expectation of two awards, suggesting competitive selection and relatively targeted, pilot-to-mid-scale projects rather than large nationwide surveillance programs. Eligible applicants are broad and include state, county, and local governments; federally recognized tribal governments and other tribal organizations; public and private institutions of higher education; nonprofit organizations with and without 501(c)(3) status; public housing authorities/Indian housing authorities; and for-profit entities including small businesses. The program is administered by HHS-FDA under CFDA number 93.103, and it falls under the activity category of Agriculture and Consumer Protection.
Overall, this opportunity is aimed at filling persistent gaps in U.S. knowledge about antimicrobial use in animal production by funding projects that can produce actionable data and, just as importantly, improve the national playbook for collecting that data in a consistent, sustainable way. The expected end value is a stronger evidence base to track progress under Guidance #213, measure and refine stewardship, and better understand how on-farm and production-level antibiotic use may relate to antimicrobial resistance risks that matter for both animal and human health.
Frequently Asked Questions (FAQs)
What is the Antimicrobial Use and Resistance Data Collection (U01) opportunity?
It is a U.S. Food and Drug Administration (FDA) cooperative agreement opportunity (RFA FD 16 046) focused on funding practical, on-the-ground data collection about how antimicrobials are used in animal agriculture, with an added emphasis on improving the methods used to collect and report those data.
Which agency is offering this funding?
The program is administered by HHS-FDA (U.S. Department of Health and Human Services, Food and Drug Administration).
What is the CFDA number for this program?
The CFDA number listed for this opportunity is 93.103.
What is the primary purpose of the program?
The central purpose is to generate credible, detailed information on real-world antimicrobial use practices in animal agriculture and to test and improve the methods used to collect and report that information so the U.S. can build better long-term monitoring systems.
Is this opportunity mainly about collecting numbers, or does it include method development too?
It explicitly includes both. FDA is looking for projects that produce substantive findings about antimicrobial use practices and also generate operational lessons about data collection methodology, including feasibility of data sources, reliability of reporting formats, barriers to collection, and approaches for standardization.
What does "U01 cooperative agreement" mean in this context?
This is described as a cooperative agreement, which generally indicates closer collaboration with FDA than a standard grant, with project activities aligned to federal monitoring and antimicrobial stewardship objectives.
Which animal sectors or production settings are in scope?
The focus is specifically on food-producing animals, with production settings explicitly including cattle, swine, and poultry.
Does the opportunity include non-food animals?
Based on the information provided, the stated focus is on food-producing animals (including cattle, swine, and poultry). No additional animal categories are specified.
What kinds of data are applicants expected to collect?
Projects are expected to capture antimicrobial use practices in real-world production contexts and produce credible, detailed information on what antimicrobials are being used, where they are used, and why. The opportunity also expects projects to produce insights into how to collect and report these data consistently.
How will FDA use the data generated from funded projects?
The data are intended to strengthen national understanding of antimicrobial use in agriculture, improve long-term monitoring approaches, support evaluation of antibiotic stewardship efforts over time, and help assess adoption of industry changes described in FDA Guidance for Industry #213.
How does this opportunity connect to the National Action Plan for Combating Antibiotic-Resistant Bacteria?
The work is positioned as directly supporting the National Action Plan objective of enhancing monitoring of antibiotic usage and management practices in food-producing animals.
What is the relevance of FDA Guidance for Industry #213 to this funding opportunity?
A stated policy linkage is FDA Guidance for Industry #213. The collected data are intended to help assess how quickly and thoroughly industry changes outlined in that guidance are being adopted, and to support evaluation of stewardship effectiveness over time.
Is antimicrobial resistance (AMR) research part of this opportunity?
The opportunity centers on antimicrobial use data collection, but it also states a purpose of supporting analysis of potential associations between antimicrobial use practices and resistance. The framing indicates FDA wants results that are useful for connecting use patterns to resistance concerns.
Is this program focused on building a nationwide surveillance system?
The description suggests relatively targeted, pilot-to-mid-scale projects rather than large nationwide surveillance programs, based on the award ceiling and the expectation of two awards.
What is the maximum award amount (award ceiling)?
The award ceiling is $300,000.
How many awards does FDA expect to make?
The opportunity indicates an expectation of two awards.
What fiscal year funds are referenced for this opportunity?
The program makes FY 2016 funds available.
When was this opportunity released and posted?
It was released and posted on March 16, 2016.
What was the application deadline?
The application deadline listed is May 24, 2016.
Who is eligible to apply?
Eligible applicants are broad and include: state, county, and local governments; federally recognized tribal governments and other tribal organizations; public and private institutions of higher education; nonprofit organizations with and without 501(c)(3) status; public housing authorities/Indian housing authorities; and for-profit entities including small businesses.
Are for-profit entities eligible?
Yes. The eligibility list includes for-profit entities, including small businesses.
Are nonprofits without 501(c)(3) status eligible?
Yes. The eligibility list explicitly includes nonprofit organizations with and without 501(c)(3) status.
Are tribal governments and tribal organizations eligible?
Yes. Eligibility includes federally recognized tribal governments and other tribal organizations.
Are institutions of higher education eligible?
Yes. Both public and private institutions of higher education are included in the eligible applicant categories.
What activity category does this opportunity fall under?
The opportunity falls under the activity category of Agriculture and Consumer Protection.
What types of outcomes are funded projects expected to deliver?
Funded projects are expected to deliver both: (1) substantive findings on antimicrobial use practices (what is used, where, and why), and (2) operational lessons that improve the national playbook for consistent, sustainable data collection (feasible data sources, reliable formats, barriers, and standardization approaches).
Why does FDA emphasize learning how to collect the "right numbers" consistently?
The opportunity highlights that improving long-term monitoring requires not just data, but repeatable and scalable collection and reporting methods. FDA is looking for projects that help identify approaches that work across different production contexts and can be standardized over time.
How does this funding relate to antibiotic stewardship in animal agriculture?
The program is intended to help evaluate the effectiveness of antibiotic stewardship efforts over time and inform how stewardship programs can be refined, expanded, and optimized based on evidence.
What broader public benefit is described for this program?
The opportunity is framed at the intersection of agriculture, consumer protection, and public health, aiming to improve transparency and decision-making around antimicrobial stewardship in the food system and to help address antimicrobial resistance risks relevant to both animal and human health.
Browse more opportunities from the same category: Agriculture, Consumer Protection
Next opportunity: OJJDP FY 16 Enhancing Forensic Capacity for Internet Crimes Against Children Task Forces
Previous opportunity: DoD Ovarian Cancer Academy - Early-Career Investigator Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA FD 16 046
[Watch] how do funding administrators access proposals?
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 16 046", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.